Skip to content
Cancer — Immune checkpoint inhibitorsATC L01FF01

Nivolumab

Prescription only

PD-1 immunotherapy, often combined with ipilimumab.

Starts working
Varies
Half-life
About 25 days
In use since
2014
Pregnancy
Usually avoided

Overview

Nivolumab (Opdivo) is a PD-1 immunotherapy used in melanoma, lung, kidney, oesophageal, bladder and other cancers, often alongside ipilimumab or chemotherapy. Its immune side effects resemble pembrolizumab's.

How it works

Releases a brake on immune cells so they attack cancer.

Nivolumab belongs to the Immune checkpoint inhibitors. How Immune checkpoint inhibitors work: remove a brake cancer cells use to hide from T-cells, so the immune system attacks the tumour. Side effects come from the immune system attacking healthy organs.

Uses

  • Melanoma
  • Lung cancer
  • Kidney cancer
  • Oesophageal and stomach cancer
  • Hodgkin lymphoma
  • Bowel cancer (MSI-high)

Available as: iv infusion, subcutaneous injection.

Typical dose

Adults
240 mg every 2 weeks or 480 mg every 4 weeks IV.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Tiredness
  • Rash
  • Diarrhoea
  • Thyroid problems

Serious — get medical help

Uncommon, but need prompt attention

  • Pneumonitis
  • Colitis
  • Hepatitis
  • Endocrine failure

Warnings

  • Report new symptoms promptly

Interactions

  • Systemic steroids before starting
Check Nivolumab against your own medicines

Pregnancy and breastfeeding

Usually avoided

Contraception needed.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Opdivo, Opdivo Qvantig
United Kingdom
Opdivo
India
Opdyta, Opdivo
Australia
Opdivo

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Why combine it with ipilimumab?

Blocking two different brakes (PD-1 and CTLA-4) boosts response in some cancers, at the cost of more side effects.

Do I need a prescription for Nivolumab?

Yes — Nivolumab is prescription-only in most countries.

Can I take Nivolumab during pregnancy?

Usually avoided. Contraception needed. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.